FDA Approved: ALVIMOPAN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for ALVIMOPAN (Actavis Pharma, Inc.), representing an additional regulatory approval step for this drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• Alvimopan (alvimopan)

Snippet

SUPPL AP for ALVIMOPAN (ALVIMOPAN)